CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Feb. 01, 2014	Feb. 02, 2013	Jan. 28, 2012
Operating activities:
Net income	$ 6,074	$ 6,833	$ 7,510
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	352	203	116
Amortization of trademarks	995	1,491	1,371
Deferred income taxes	(176)	(139)	921
Stock-based compensation including tax effect	784	967	573
Other, net	(44)	84	37
Changes in operating assets and liabilities:
Receivables	(909)	173	1,287
Prepaids and other current assets	133	(293)	(44)
Income taxes receivable	527	599
Accounts payable and other accrued payables	581	383	(82)
Deferred revenue	14	(547)	(233)
Income taxes payable	75	239	(50)
Accrued compensation	214	(205)	(4,046)
Net cash provided by operating activities	8,620	9,788	7,360
Investing activities:
Purchases of trademarks, including registration and renewal cost	(19,053)	(18,026)	(258)
Purchase of property and equipment	(629)	(491)	(676)
Net cash used in investing activities	(19,682)	(18,517)	(934)
Financing activities:
Proceeds from US Bank Term Loan and promissory note			10,000
Proceeds from JPMorgan Term Loan	19,000	17,250
Payments of US Bank Term Loan and promissory note		(6,938)	(10,322)
Payments of JPMorgan Term Loan	(3,308)	(650)
Debt discount and deferred financing costs	(95)	(129)
Proceeds from exercise of stock options	36	72	161
Proceeds from issuance of common stock			200
Repurchase of common stock			(1,885)
Dividends	(3,361)	(5,873)	(6,746)
Net cash provided by (used in) financing activities	12,272	3,732	(8,592)
Increase (decrease) in cash and cash equivalents	1,210	(4,997)	(2,166)
Cash and cash equivalents at beginning of period	2,424	7,421	9,587
Cash and cash equivalents at end of period	3,634	2,424	7,421
Cash paid during period for:
Income taxes	3,240	3,667	2,127
Interest	455	240	244
Non-cash financing activities:
Accrued and declared dividends		$ 840	$ 1,677